Phase Ib study of venadaparib, a potent and selective PARP inhibitor, in homologous recombination repair (HRR) mutated breast cancer

  • Im, S-A.; 
  • Kim, J. E.; 
  • Lee, K. S.; 
  • Moon, Y. W.; 
  • Ahn, H. K.; 
  • 외 7명
Citations

WEB OF SCIENCE

1
제목
Phase Ib study of venadaparib, a potent and selective PARP inhibitor, in homologous recombination repair (HRR) mutated breast cancer
저자
Im, S-A.; Kim, J. E.; Lee, K. S.; Moon, Y. W.; Ahn, H. K.; Ock, C-Y.; Roh, E-J.; Lee, M.; Hong, M. J.; Song, S.; Lee, K-H.; Lee, W. S.
DOI
10.1016/j.annonc.2021.08.553
발행일
2021-09
유형
Meeting Abstract
저널명
Annals of Oncology
권
32
페이지
S480 ~ S480